Nature Communications (Jan 2022)
Host receptor-targeted therapeutic approach to counter pathogenic New World mammarenavirus infections
Abstract
Five New World mammarenaviruses (NWMs) enter cells via binding to human transferrin receptor 1 (hTfR1). Here, Hickerson et al. show that hTfR1 targeting antibodies partially protect hTfR1-transgenic mice from lethal NWM challenge via competition of anti-hTfR1 antibody and viral glycoprotein for hTfR1.